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ABSTRACT 
 
Assisted Reproductive Technology (ART) has been developed to be used for reproductive-age women with primary 
and secondary infertilities. Obesity is a worldwide epidemic for both women and men and a major global health 
concern. The direct effect of Body Mass Index (BMI) increase on the outcomes of ART is still unclear. This study 
aimed to carry out a systematic review of the available scientific evidence to assess the effects of obesity on the 
clinical outcome of ART treatment. Numerous studies have shown failure in ART due to increased BMIs in infertile 
women; however, the impact of increased BMI on clinical effectiveness of ART still remains inconclusive. Using 
results from 44 studies (831616 subjects) we conducted an updated systematic review and meta-analysis to highlight 
this subject (clinical pregnancy rate, miscarriage rate and live-birth rate). Compared to the women with BMIs of 25 
kg/m2 or less, women with BMI ≥ 25 kg/m2 have a lower chance of pregnancy [risk ratio 0.91, 95% CI: 0.89-0.94] 
as well as lower live-birth rates [risk ratio 0.81, 95% CI: 0.70-0.94], and show increased miscarriage rates [risk 
ratio 1.35, 95% CI: 1.28-1.46]. Our findings indicate that elevated BMI and obesity requires more recognition as a 
potential contributor to negative pregnancy outcomes and reduced live-birth following ART. The results of our 
meta-analysis suggest that weight loss should be considered in overweight and obese women before the initiation of 
infertility treatment. 
 
Key words: Obesity, Assisted Reproductive Technology, systematic review, clinical pregnancy rate, live-birth rate, 
miscarriage rate. 
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INTRODUCTION 
 
In vitro fertilization (IVF), frozen embryo transfer (FET) and intra-cytoplasmic sperm injection (ICSI) were first 
reported in 1978, 1984, and 1992, respectively. [1-3]. The Assisted Reproductive Technology (ART) has been 
developed to be used for reproductive-age women with primary and secondary infertilities. Recent estimates indicate 
that 1.7% to 4.0% of pregnancies in industrialized and developed countries had positive outcomes of ART [4]. Most 
of the pregnancies resulting from ART process did not show any complications and resulted in healthy children [5]. 
Therefore, ART represents an important and useful tool and that could be used more widely in the future. Obesity is 
a worldwide epidemic for both women and men and represents still today a major global health concern. Rates of 
obesity have more than doubled since 1980. In 2014 more than 1.9 billion adults were overweight and 600 million 
were obese [6].  
 
The World Health Organization (WHO) defined the obesity as Body Mass Index (BMI=weight/height2 and 
expressed as kg/m2) ≥ 30 kg/m2 [Table 1], however, many authors used variable body mass index (BMI) cut-off 
values to define obesity. Obesity is associated with cardiovascular disease, diabetes, osteoarthritis and malignancies 
[6]. It is increasingly being recognized that this current obesity epidemic has also contributed to fertility problems. 
Both populations in developing and developed countries show an increase of overweight or obese  people and 0.5% 
of the population in some developing countries to 50% or more in some developed countries is overweight or obese 
[7-9]. 
 
Table 1: The international classification of adult underweight, overweight and obesity according to BMI 
 
Classification BMI (kg/m2) cut-off points 
Underweight <18.50 
Normal range 18.50 - 24.99 
Overweight 25.00- 29.99 
Obese ≥30.00 
Source: Adapted from WHO, 1995, WHO, 2000 and WHO 2004. 
 
For the women undergoing ART, although there are contradictory results regarding the effect of raised BMI on the 
outcomes of ART, several meta-analyses studies have recently demonstrated that excess weight and elevated BMI is 
associated with: decreased pregnancy rate, lower Birth Rate (LBR), lower Implantation Rate (IR), higher 
Miscarriage Rate (MR) and with the possibility of reduction of follicle development as also of oocyte’s numbers as 
well as an increased gonadotropin requirement following the ART [10-12]. However, several studies have been 
unable to find any negative impact of obesity on ART outcomes [13, 14]. 
 
Available studies on the obesity effects on women on following in ART treatments show variable results. The aim of 
our study is to carry out an updated systematic review of literature in order to definitively verify whether excessive 
weight and the increased BMI adversely affect on the clinical outcomes (LBR, IR, MR) of ART, and if so, to assess 
the size of this effect. 
 
MATERIALS AND METHODS 
 
Literature search 
We conducted a comprehensive review of all studies containing data on overweight and BMI and clinical outcomes 
for patients treated with any form of ART. We used a systematic approach to search the literature according to 
PRISMA method [15]. On October 29, 2016, we carried out searches through PubMed, Web of Science and Scopus 
by using the search string: “(body mass index OR obesity OR overweight) AND (assisted reproductive techniques 
OR in vitro fertilization or intracytoplasmic sperm injection) AND (women or female) AND (live birth rate OR 
pregnancy rate OR miscarriage)”. In addition, manual reference checks were performed of references of accepted 
articles and reviews published within the last 2 years. No language restrictions were used in our search. After 
removing duplicates, 458 potentially relevant articles remained (Fig. 1). Titles and abstracts were then screened (by 
HHK and ZB) and reviews and irrelevant studies were removed, leaving us finally with 85 potentially relevant 
studies (Fig. 1). 
 
2.2. Study selection, eligibility criteria and Data extraction 
Two authors (KM, SRC) independently searched the eligible studies and a final study set for data extraction was 
identified by consensus. Studies were included if they investigated the effect of BMI on pregnancy outcome (Table 
1) in women undergoing ART treatment. From each relevant study one author (SA) abstracted the following 
information (population size, study design, BMI categories used and population numbers in each category and 
outcome measures) which was checked by two others colleagues (HHK and LD) (see Table 2).  
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Statistical analysis 
We pooled outcome data from each study and expressed as risk ratio (RR) with 95% confidence interval (CI) by 
using either a fixed-effect model [16] or a random-effect model [17] through a statistical software program 
Comprehensive Meta-Analysis V2.0 (Biostat, Englewood, NJ). We assessed heterogeneity of treatment effects in 
our meta-analytic model using the I2 statistic [18] and described graphically through the forest plots [19] to quantify 
the variation across studies caused by heterogeneity. If significant heterogeneity was observed (p < 0.10 or p > 0.10 
but I2 > 50%), the meta-analyses were conducted using a random effect model. A fixed effect model was used for 
the meta-analysis where heterogeneity was acceptable (p > 0.10, or p < 0.10 but I2 < 50%). 
 
RESULTS 
 
Analysis and pooling of data 
The literature analysis was presented as a PRISMA diagram (Fig. 1) . From 85 studies fulfilling the inclusion criteria 
only 44 studies had cut-off values for BMI according to the WHO criteria, which included data for meta-analysis 
(Table 2).  
 
Out of the 44 studies, only four studies were prospective observational, the remaining were retrospective studies. All 
the included studies were cohort studies except for one case control study [20]. Of the 44 studies included in the 
final meta-analysis, 28 studies reported on the miscarriage rates in pregnancies conceived following ART, 19 and 35 
studies reported on live birth rate and pregnancy rate following ART, respectively. 
 
In total, 44 studies including 831616 IVF/ICSI cycles were included in the review with a total of BMI<25 kg/m2, 
n=505475; and BMI ⩾25 kg/m2, n=831616. 
 
A random effect model was used to calculate risk ratios (RR) (95% CI). Tests of heterogeneity were performed 
before to pooling of data.  
 
Fig 1. Flow diagram detailing the search and inclusion of studies in our review, as suggested by the PRISMA statement 
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Results of the aggregated data 
Pooled results were described separately for BMI ≥ 25 versus < 25. In addition, outcomes per cycle were aggregated 
together and described separately.  
 
Live birth rate 
In women with BMI of < 25, the risk ratio of pooled results from 19 studies was 0.81 (95%: CI 0.70-0.94), when 
compared with women with BMI of ≥ 25 (Figure 2). The pooled results showed a statistically significant reduction 
in the live-birth rate in women with BMI ⩾25 kg/m2 compared with women with BMI < 25 kg/m2. The live birth 
rate is reduced by approximately 18 % (95 %: CI 5.6-29.2) in women BMI ⩾25 kg/m2 when compared with women 
with BMI < 25 kg/m2. There was significant statistical heterogeneity between the included studies (I2=99.35%. P = 
0.000).  
 
Fig 2. Forest plot of risk ratio live-birth rate in women with BMI < 25 versus BMI ≥ 25 
 
Pregnancy rate 
In women with BMI of < 25, the risk ratio of pooled results from 35 studies was 0.91 (95%: CI 0.89-0.94) when 
compared with women with BMI of ≥ 25. The pooled results showed a statistically significant reduction in the 
pregnancy rate in women with BMI ⩾25 kg/m2 compared with women with BMI < 25 kg/m2. The pregnancy rate is 
reduced by 8.4 % (95 %: CI 6-10.7) in women BMI ⩾25 kg/m2 when compared with women with BMI < 25 kg/m2. 
Again there was significant statistical heterogeneity between the included studies (I2=60.91 %. P = 0.000).  
 
 
Fig 3. Forest plot of pregnancy rate in women with BMI < 25 versus BMI ≥ 25 
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Table 2. Characteristics of the included studies 
 
 
Authors Year Study design Participant groups BMI group (kg/m2) and numbers of 
cycles/patients 
Outcome measures Referenc
e 
Wittemer et al.  2000 Retrospective  All couples referred for IVF/ICSI Excluded 
PCOS 
<20: 87 Women 
20–25: 222 Women 
⩾25:, 89 Women 
Pregnancy rate 
Miscarriage rate 
Delivery rate 
[21] 
Wang et al. 2000 Retrospective  All women undergoing ART (IVF/ ICSI/GIFT) < 20: 441 women  
20–24.9: 1910 women  
25–29.9: 814 women  
30–34.9: 304 women  
≥ 35: 117 women 
Clinical pregnancy rate [22] 
Fedorcsak et al.  
 
2000 Cohort study  Women pregnant as a result of IVF or ICSI < 25: 304 pregnancies  
≥ 25: 79 pregnancies 
Miscarriage rate [23] 
Loveland et al. 2001 Retrospective All women undergoing IVF/ICSI cycles ≤25: 87 cycles, 70 women  
>25: 93 cycles, 69 women 
Clinical pregnancy rate  
Spontaneos abortion 
Ongoing pregnancy rate 
[24] 
Wang et al. 2001 Cohort All women undergoing ART (IVF/ ICSI/GIFT) <20: 112 Women 
20–24.9: 509 Women 
25–29.9: 231 Women 
30–34.9: 116 Women 
⩾35: 50 Women 
Spontaneous abortion [25] 
Ferlitsch et al. 2002 Retrospective All women undergoing IVF <20: 31 Women 
20–24.9: 104 Women 
25–30: 31 Women 
>30: 16 Women 
pregnancy rate [26] 
Krizanovska et al. 2002 Retrospective Women undergoing IVF and ICSI <16: 2 Women 
18–20: 30 Women  
20–25: 173 Women 
25–30: 79 Women 
⩾30: 25 Women 
Clinical pregnancy 
Miscarriage rate 
[27] 
Wang et al. 2002 Retrospective All women undergoing ART (IVF/ ICSI/GIFT) 
 
<18.5: 70 Women 
18.5–24.9: 1508 Women 
25–29.9: 503 Women 
30–34.9: 198 Women 
⩾35: 70 Women 
Spontaneous miscarriage [28] 
Winter et al. 2002 Cohort All women undergoing ART (IVF/ ICSI/GIFT) 
 
<18.5: 26 Women 
18.5–25: 701 Women 
25.1–30: 243 Women 
30.1–35: 107 Women 
>35: 46 Women 
Early pregnancy loss [29] 
Doody et al. 2003 Retrospective Women undergoing IVF and ICSI <25: 460 Women 
25–29.9: 194 Women 
30–34.9: 89 Women 
>35: 79 Women 
Ongoing pregnancy rate [30] 
Ryley et al. 2004 Retrospective Women undergoing IVF <20: 466 Cycles 
20–24.9: 3605 Cycles 
Clinical pregnancy rate [31] 
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25–29.9: 1632 Cycles 
30–34.9: 724 Cycles 
>35: 400 Cycles  
Fedorcsak et al. 2004 Retrospective Women undergoing IVF and ICSI <18.5: 76 Women, 136 cycles 
18.5–24.9,: 1839 Women, 3457 cycles 
25–29.9: 504 Women, 963 cycles 
⩾30: 241 Women, 463 cycles 
Pregnancy rate 
Miscarriage rate 
Live birth rate 
[32] 
Hammadeh et al. 2005 Prospective Women undergoing IVF ⩽25: 28 Women 
>25: 24 Women 
Pregnancy rate [33] 
Munz et al. 2005 Retrospective case–
control 
Women undergoing IVF and ICSI <25: 28 Women 
>25: 24 Women 
Pregnancy rate [20] 
Van Swieten et 
al. 
2005 Observational study Women undergoing IVF and ICSI < 25: 683women 
25–29.9: 295 women  
30-39.9: 236 women 
≥ 79: 29 women 
Clinical pregnancy rate  
Miscarriage rate 
[34] 
Dokras et al. 2006 Retrospective Women undergoing IVF < 25: 101women 
25–30: 32 women  
≥ 30: 29 women 
Pregnancy rate 
Miscarriage rate 
Delivery rate 
[35] 
Mitwally et al. 2006 Cohort Women undergoing IVF <25: 102 Cycles 
⩾25: 81 Cycles 
Clinical pregnancy rate [36] 
Dechaud et al. 2006 Retrospective Women undergoing IVF and ICSI <20: 186 Women, 264 cycles 
20–25: 283 Women, 394 cycles 
25–30: 68 Women, 83 cycles 
⩾30: 36 Women, 48 cycles 
Clinical pregnancy rate 
Miscarriage rate 
[14] 
Metwally et al. 2007 Retrospective Women undergoing IVF and ICSI 19–24.9: 241 Women 
25–29.9: 113 Women 
⩾30: 72 Women 
Clinical pregnancy rate [37] 
Lenoble et al.  2008 Retrospective Women undergoing IVF and ICSI ⩽18: 43 Women, 68 cycles 
18–25: 607 Women, 1045 cycles 
⩾25: 196 Women, 331 cycles 
Clinical pregnancy rate 
Miscarriage rate 
[38] 
Martinuzzi et al. 2008 Retrospective Women undergoing IVF and ICSI <18.5: 21 Women 
18.5–24.9: 267 Women 
25–29.9: 77 Women 
⩾30: 52 Women 
Clinical pregnancy rate [39] 
Moini et al.  2008 Cross-sectional Women undergoing IVF and ICSI 20–25: 133 Women 
>25–30: 117 Women 
>30: 37 Women 
Clinical pregnancy rate 
Miscarriage rate 
[40] 
Sneed et al. 2008 Retrospective Women undergoing IVF <18.5: 28 Women 
>18.5–24.9: 613 Women 
>25–29.9: 325 Women 
>30: 307 Women 
Spontaneous abortion 
Clinical pregnancies 
Live births 
[41] 
Esinler et al.  2008 Retrospective Women undergoing ICSI 18.5–24.9: 451 Women, 627 cycles 
25–29.9: 222 Women, 339 cycles 
⩾30: 102 Women, 147 cycles 
Clinical pregnancy rate 
miscarriages rate 
[42] 
Orvieto et al. 2009 Retrospective Women undergoing IVF ⩽25: 42 Women 
>25: 58 Women 
Pregnancy rate [43] 
Bellver et al.  2010 Retrospective Women undergoing IVF and ICSI <20: 1070 Cycles Pregnancy rate [44] 
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20–24.9: 3930 Cycles 
25–29.9: 1081 Cycles 
⩾30: 419 Cycles 
Early pregnancy loss rate 
Clinical miscarriage rate 
Live-birth rate 
Chueca et al. 2010 Retrospective Women undergoing IVF <20: 1289 Cycles 
20–25: 3382 Cycles 
>25–30: 755 Cycles 
>30: 293 Cycles 
Clinical Pregnancy rate 
miscarriage rate 
 
[45] 
Farhi et al. 2010 Retrospective Women undergoing IVF ⩽25: 160 Cycles 
>25: 73 Cycles 
Pregnancy rate [46] 
Kilic et al. 2010 Retrospective Women undergoing ART 18–24.9: 718 Women 
25–29.9: 470 Women 
⩾30: 782 Women 
Clinical Pregnancy rate [47] 
Zhang et al. 2010 Cohort study Women undergoing IVF and ICSI 18.5–25: 2222 Women 
>25–29.9: 379 Women 
⩾30: 27 Women 
Pregnancy rate 
Miscarriage rate 
Ongoing pregnancy rate 
Live-birth rate 
[48] 
Rittenberg et al. 2011 Cohort study 
 
Women undergoing IVF and ICSI 18.5–24.9: 244 Women 
⩾25: 169 Women 
Clinical pregnancy rate 
Implantation rate 
Miscarriage rate 
Ongoing pregnancy rate 
[49] 
Pinborg et al. 2011 Cohort study 
 
Women undergoing IVF and ICSI <18.5: 24 Women 
18.5–24.9: 305 Women 
25–29.9: 103 Women 
⩾30: 59 Women 
Pregnancy rate 
Miscarriage rate 
Ongoing pregnancy rate 
Live-birth rate 
[50] 
Setti et al.  2012 Retrospective Women undergoing ICSI <19: 39 Women 
19–24.9: 738 Women 
25–29.9: 242 Women 
⩾30: 86 Women 
Pregnancy rate 
Miscarriage rate 
[51] 
Tu et al.  2014 Retrospective Women undergoing IVF and ICSI ⩽25: 387 Women 
>25: 112 Women 
Clinical PR per experimental 
therapeutics 
Miscarriage rate 
Live birth rate per ET 
 
[52] 
Bailey et al.  2014 Retrospective cohort PCOS women undergoing IVF 
 
18.7-24.9: 51 Women 
25–29.9: 19 Women 
⩾30: 31 Women 
Clinical pregnancy per ET 
Miscarriage 
Live-birth rate per cycle start and ET 
 
[53] 
Schliep et al.  2014 Prospective cohort All couples undergoing first fresh IVF cycles <18.5: 32 Women 
18.5–24.9: 407 Women 
25–29.9: 147 Women 
30-34.9: 72 Women 
⩾35: 63 Women 
pregnancy rate 
Live-birth rate 
[54] 
Vural et al.  2014 Retrospective cohort Women undergoing IVF <25: 452 Women 
25–30: 230 Women 
⩾30: 98 Women 
Clinical Pregnancy rate [55] 
Ozekinci et al. 2015 Retrospective cohort Women younger than 38 years old undergoing 
Ivf-icsi 
18.5-24.9: 164 Cycles  
25–29.9: 70 Cycles  
⩾30: 64 Cycles 
Clinical pregnancy rate 
Spontaneous abortion 
Ongoing pregnancy  
[56] 
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Caillon et al. 2015 Retrospective Women undergoing IVF and ICSI 20-24.9: 409 Women 
⩾25: 149 Women 
Miscarriage rate 
Live-birth rate per cycle 
[57] 
Kalem et al.  2016 Retrospective cohort PCOS women undergoing IVF 18.5–24.9: 299 Women 
25–29.9: 208 Women 
⩾30: 146 Women 
Clinical pregnancy rate [58] 
Christensen et al. 2016 Historical cohort Women undergoing IVF and ICSI <18.5: 159 Cycles 
18.5–24.9: 35339 Cycles 
25–29.9: 1171 Cycles 
⩾30: 474 Cycles 
Clinical pregnancy rate [59] 
Wang et al.  2016 Retrospective cohort Women undergoing IVF and ICSI <25: 7097 Cycles 
⩾25: 1768 Cycles 
Clinical pregnancy rate 
Abortion 
Live-birth rate 
[60] 
Kawwass et al.  2016 Retrospective cohort Women undergoing IVF  <18.5: 13678 Cycles 
18.5–24.9: 271985 Cycles 
25–29.9: 116788 Cycles 
⩾30: 91646 Cycles 
Intrauterine pregnancy rate 
Miscarriage rate 
Live-birth rate 
[61] 
Provost et al.  2016 Retrospective cohort Women undergoing IVF  <18.5: 7149 Cycles 
18.5–24.9: 134588 Cycles 
25–29.9: 54822 Cycles 
30–34.9: 24992 Cycles 
35–39.9: 11747 Cycles 
40–44.9: 4084 Cycles 
45–49.9: 1292 Cycles 
⩾50: 463 Cycles 
Clinical pregnancy rate 
Pregnancy loss rate 
Live birth rate 
[62] 
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Miscarriage rate 
In women with BMI of < 25, the risk ratio of pooled results from 28 studies was 1.35 (95%: CI 1.28-1.46), when 
compared with women with BMI of ≥ 25 (Figure 4). The pooled results showed a statistically significant increase in 
the miscarriage rate in women with BMI ⩾25 kg/m2 compared with women with BMI<25 kg/m2. The miscarriage 
rate is increased by approximately 35 % (95 %: CI 25-45) in women BMI ⩾25 kg/m2 when compared with women 
with BMI < 25 kg/m2. The results showed evidence of statistical heterogeneity (I2=71.5 %. P = 0.000). 
 
 
Fig 4. Forest plot of miscarriage rate in women with BMI < 25 versus BMI ≥ 25 
 
Publication bias 
The funnel plot for all outcome measures of ART that evaluated in this study, was asymmetric (Fig. 5) and with the 
results of Egger test (Table 3) suggesting small-study bias. 
 
DISCUSSION 
 
Obesity is an expensive and increasingly prevalent health burden upon modern society [63]. Obesity is an abnormal 
accumulation of body fat, generally 20% or more over an individual's ideal body weight. Obesity is associated with 
increased risk of illness, disability, and death. Obesity is often a comorbidity of other pathologies such as 
cardiovascular disease, hypertension, type 2 diabetes, gastrointestinal disease, arthritis, and cancer, also obese 
women are more likely to experience reproductive problems [6, 64-66]. Obesity has been attributed to menstrual and 
hormonal disorders, loss of fertility, miscarriage, undesired obstetric consequences (such as congenital defects and 
premature birth) and obstetric complications (e.g. increased blood pressure, pregnancy diabetes and wound 
infection) [67-70]. In addition, obesity is encountered in 30% to 70% of women with polycystic ovary syndrome 
[71]. Consequently, number of infertile overweight and obese women who are subjected to ART as a treatment for 
infertility is increasing steadily in worldwide [11, 72], thus, the impact of overweight and increased BMI on the 
outcome of ART treatment is of interest to patients, clinicians and makers of public health. 
 
Our meta-analysis included data on 831616 subjects treated with ART, extracted from 44 studies. The result of our 
meta-analysis suggests that overweight women face a lower likelihood of: pregnancy , a live birth and an increased 
risk of miscarriage after IVF.  
 
The results of our review are in accordance with a previous review and meta-analysis [11] and indicate that women 
who are overweight or obese (BMI ⩾25 kg/m2) have adverse outcomes following ART treatment compared with 
women with normal BMI. Unlike the previous systematic reviews [10, 37] our data demonstrate that positive 
clinical outcomes of ART treatment decrease in women overweight and with an increased BMI of and also, the 
raised BMI is associated significantly with a reduced live-birth rate and increased miscarriage rate after ART 
treatment. 
 
It is, however, possible to deduce from the available data that an apparent decrease in implantation rate and higher 
miscarriage in overweight and obese women it reflects in a reduced expectation of live birth rate. 
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Fig 5. Funnel plot of (A) clinical pregnancy rate, (B) miscarriage rate and (C) live birth rate for assessing potential publication 
bias. The diagonal lines indicates approximate 95% confidence intervals for estimates. 
 
  
Table 3. The results of Egger test for funnel plot asymmetry. 
 
Outcome of ART t value df p value (1-tailed) p value (2-tailed) 
Pregnancy rate  0.791 35 0.217 0.434 
Live-birth rate 0.663 18 0.257 0.515 
Miscarriage rate 1.535 22 0.069 0.138 
 
While give in consultation to the infertile obese women who require ART to conceive, it is of note to know that 
pregnancy rate in overweight and obese women is still good, and age is the overriding factor in predicting success 
following ART [73]. 
 
The results of this study show that the live-birth rate and pregnancy rate is reduced by 19 % (95% CI 6–30%) and 
8.4 % (95 %: CI 6-10.7), respectively, in women with BMI⩾25 kg/m2 when compared with women with BMI lower 
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than 25 kg/m2 following infertility treatment. Also the miscarriage rate is increased by approximately 35 % (95 %: 
CI 25-45) in women BMI ⩾25 kg/m2 when compared with women with BMI < 25 kg/m2. 
 
Waist-to-hip ratio (WHR) is a value derived from the waist measurement and hip measurement and calculated as 
waist measurement divided by hip measurement (W ÷ H). The WHR may be used as a possible indicator of health 
issues, but also as risk of developing serious health conditions. WHR is correlate with infertility problem in males 
and females, but with different optimal values. There are suggestions that WHR is a better predictor of reproductive 
outcome than BMI [10, 74, 75] because the BMI does not differentiate between android and gynaecoid fat 
distribution, although in this review, we have used BMI as a marker of overweight and obesity. 
 
Underlying mechanisms that linking the elevated BMI with the poorer outcomes after ART are not fully understood, 
though three hormonal systems—the insulin and insulin-like growth factor (IGF) axis (insulin resistance), sex 
steroids (hyperandrogenism and LH hypersecretion) and adipokines (elevated leptin levels and leptin resistance)—
are the most studied candidates [65, 76-79]. All three systems are interlinked through insulin. 
 
Adiponectin is a ubiquitous fat tissue hormone which is mainly produced from the cells of visceral fat and has been 
shown to have an inverse association with BMI. Mean circulating concentrations are higher in women than men [65, 
80]. Beyond these mechanisms, other candidate systems include obesity-related inflammatory cytokines, altered 
immune response, oxidative stresses and lipid peroxidation [81, 82]. We do not yet know what mechanisms might 
link the clinical outcomes of ART with obesity. 
 
Raised BMI through mechanisms that were mentioned above could adversely affect folliculogenesis, oocyte 
maturation and embryonic competence. Elevated BMI could be also associated with impaired implantation and 
increased risk of miscarriage; thus affecting ART outcome [81-86].  
 
The results of our review are not completely free from bias and should be interpreted with caution. Methodological 
and clinical heterogeneity arises through the use of different study designs, particularly in relation to study 
population characteristics and definition of the relevant outcome measures. More study in this field is needed with 
clearly defined patient populations, using WHO criteria for BMI and uniform outcome measures to determining 
effect of raised BMI on reproductive outcomes following the ART treatment. 
The findings of our review and other systematic review and meta-analysis studies permit clinicians to provide more 
detailed advice regarding the impact of elevated BMI and obesity on outcome of treatment before initiating an ART 
cycle. The obese infertile patients with abnormal BMI should be encouraged to lose weight and improve exercise 
tolerance to improve the clinical outcomes after ART treatment and to prepare for the stresses during pregnancy and 
at the moment of labour. 
 
CONCLUSION 
 
In conclusion, this systematic review and meta-analysis clearly demonstrates that raised BMI has an adverse effect 
on the outcome of ART. Obesity and overweight is associated with decreased pregnancy as well as higher 
miscarriage rates and decreased live birth rate following infertility treatment. Weight loss should be strongly 
considered in overweight and obese women before initiating infertility treatments. This will result in better health 
conditions of women undergoing infertility treatment, improving their chances of pregnancy and minimizing the 
costs of infertility treatment. 
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